Acitretin

Product manufactured by Avkare, Inc.

Application Nr Approved Date Route Status External Links
ANDA204633 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Acitretin Capsules, Usp Are Indicated For The Treatment Of Severe Psoriasis In Adults. Because Of Significant Adverse Effects Associated With Its Use, Acitretin Capsules, Usp Should Be Prescribed Only By Those Knowledgeable In The Systemic Use Of Retinoids. In Females Of Reproductive Potential, Acitretin Capsules, Usp Should Be Reserved For Non-Pregnant Patients Who Are Unresponsive To Other Therapies Or Whose Clinical Condition Contraindicates The Use Of Other Treatments (see Boxed Contraindications And Warnings — Acitretin Capsules, Usp Can Cause Severe Birth Defects). Most Patients Experience Relapse Of Psoriasis After Discontinuing Therapy. Subsequent Courses, When Clinically Indicated, Have Produced Efficacy Results Similar To The Initial Course Of Therapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Acitretin ACITRETIN ZINC3798734

Comments